Divis Laboratories Ltd | DIVI - Capitaux D'Emprunt

Prix De L'Action
6,116.50
Variation Quotidienne
164.00 2.76%
Mensuellement
-3.72%
Annuel
9.43%
Q2 Prévisions
5,728.83




Capitaux D'Emprunt Changement Date
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Aurobindo Pharma INR 12.82B 5.19B 2025-09
Avita Medical AUD 42.24M 1.25M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Lupin INR 18.45B 1.86B 2025-09
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Revvity USD 2.63B 543K 2025-12
Tectonic Therapeutic USD 43K 57K 2025-12
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12